» Articles » PMID: 32095500

Evaluation of Intrahepatic Lactate/Pyruvate Ratio As a Marker for Ischemic Complications Early After Liver Transplantation-A Clinical Study

Overview
Publisher Wolters Kluwer
Specialty General Surgery
Date 2020 Feb 26
PMID 32095500
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lactate/pyruvate ratio has been introduced as a sensitive marker for ischemia in the transplanted liver. In the present study, we aimed to evaluate lactate/pyruvate ratio measured in the liver by microdialysis as a marker for ischemic complications early after liver transplantation.

Methods: Forty-five patients undergoing liver transplantation were included in the study. A microdialysis catheter was placed in the liver graft directly following liver transplantation and the metabolites lactate and pyruvate measured for up to 6 days and the lactate/pyruvate ratio calculated. The association between increased intrahepatic lactate/pyruvate ratio and ischemic complications was studied.

Results: One of 45 patients developed hepatic arterial thrombosis. Forty-four events with increased lactate/pyruvate ratio were identified in 24 patients. In none of the 24 patients that had a raised lactate/pyruvate ratio could we detect occurrence of any ischemic complication. In the patient that did have hepatic arterial thrombosis, the lactate/pyruvate ratio did not show a significant prolonged rise.

Conclusions: An increase in the intrahepatic lactate/pyruvate ratio is not necessarily indicative of ischemic complications and is thus not a reliable marker for monitoring of clinically significant ischemia in the liver early after transplantation.

Citing Articles

Liver transplant and the sweet-bitter truth.

Suresh V, Magoon R, Mahajan S Anesth Pain Med (Seoul). 2022; 17(2):247.

PMID: 35538658 PMC: 9091662. DOI: 10.17085/apm.22140.


Microdialysis and CO2 sensors detect pancreatic ischemia in a porcine model.

Rydenfelt K, Strand-Amundsen R, Horneland R, Hodnebo S, Kjosen G, Pischke S PLoS One. 2022; 17(2):e0262848.

PMID: 35143517 PMC: 8830677. DOI: 10.1371/journal.pone.0262848.


Clinical assessment of liver metabolism during hypothermic oxygenated machine perfusion using microdialysis.

Patrono D, Roggio D, Mazzeo A, Catalano G, Mazza E, Rizza G Artif Organs. 2021; 46(2):281-295.

PMID: 34516020 PMC: 9292750. DOI: 10.1111/aor.14066.


An Increased Lactate-to-pyruvate Ratio Is Not a Stand-alone Marker of Ischemia.

Haugaa H, Line P, Tonnessen T Transplant Direct. 2020; 6(5):e551.

PMID: 32548245 PMC: 7213610. DOI: 10.1097/TXD.0000000000000991.

References
1.
Nowak G, Ungerstedt J, Wernerman J, Ungerstedt U, Ericzon B . Metabolic changes in the liver graft monitored continuously with microdialysis during liver transplantation in a pig model. Liver Transpl. 2002; 8(5):424-32. DOI: 10.1053/jlts.2002.32943. View

2.
Nowak G, Ungerstedt J, Wernerson A, Ungerstedt U, Ericzon B . Hepatic cell membrane damage during cold preservation sensitizes liver grafts to rewarming injury. J Hepatobiliary Pancreat Surg. 2003; 10(3):200-5. DOI: 10.1007/s00534-002-0760-4. View

3.
Hovda D, Lee S, Smith M, Von Stuck S, Bergsneider M, Kelly D . The neurochemical and metabolic cascade following brain injury: moving from animal models to man. J Neurotrauma. 1995; 12(5):903-6. DOI: 10.1089/neu.1995.12.903. View

4.
Hillered L, Persson L . Neurochemical monitoring of the acutely injured human brain. Scand J Clin Lab Invest Suppl. 1999; 229:9-18. DOI: 10.1080/00365519950185904. View

5.
Shay R, Taber D, Pilch N, Meadows H, Tischer S, McGillicuddy J . Early aspirin therapy may reduce hepatic artery thrombosis in liver transplantation. Transplant Proc. 2012; 45(1):330-4. DOI: 10.1016/j.transproceed.2012.05.075. View